Skip to main content
. 2009 Mar 9;27(11):1806–1813. doi: 10.1200/JCO.2008.17.7188

Fig A1.

Fig A1.

(A) Positive Dpc4 immunolabeling in a locally advanced carcinoma that was associated with limited metastatic disease burden (< 10 documented metastase). (B) Loss of Dpc4 immunolabeling in a primary carcinoma associated with widespread metastatic disease (> 1,000 documented metastases).